Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Bayer AG
  6. News
  7. Summary
    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 11/29 04:00:00 pm
45.53 EUR   -0.02%
11/24Johnson Matthey to buy back shares as profit jumps
RE
11/22BAYER AG : Goldman Sachs reiterates its Buy rating
MD
11/19Bayer shortlists private equity firms to bid for pest control unit -Handelsblatt
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Bayer shares tumble as judge rejects Roundup deal

05/27/2021 | 09:19am EST

Bayer shares tumbled as much as 5% on Thursday (May 27).

That after a U.S. judge threw out its bid to limit the cost of future class action lawsuits.

The cases concern allegations that its Roundup weedkiller causes cancer.

Bayer had offered to settle around 30,000 claims, in return for placing limits on the suits.

But that was rejected by the judge, who called the plan "unreasonable".

Now a lawyer for the German firm says it will ask the Supreme Court to quash defeats it suffered in jury trials.

Bayer points out that its product was deemed safe by the U.S. Environmental Protection Agency.

However, three cases have so far gone to trial, and in each one juries awarded tens of millions of dollars in damages.

About 125,000 people have alleged that Roundup caused their cancer.

Some 96,000 of those cases were resolved with a $9.6 billion dollar settlement.


ę Reuters 2021
All news about BAYER AG
11/24Johnson Matthey to buy back shares as profit jumps
RE
11/22BAYER AG : Goldman Sachs reiterates its Buy rating
MD
11/19Bayer shortlists private equity firms to bid for pest control unit -Handelsblatt
RE
11/19Uni?o Qu?mica Farmac?utica Nacional S.A. completed the acquisition of Cancioneiro Plant..
CI
11/18MarketScreener's World Press Review - November 18, 2021
11/18Bayer To Keep Business Divisions Under One Roof, CEO Says
MT
11/18Breaking up is not for us, Bayer CEO says
RE
11/17Couple's $86M reward in Monsanto pesticide case stands
AQ
11/17Bayer Partners With Microsoft To Develop New Digital Solutions
MT
11/16BAYER AG : Barclays reiterates its Neutral rating
MD
More news
Analyst Recommendations on BAYER AG
More recommendations
Financials
Sales 2021 42 956 M 48 485 M 48 485 M
Net income 2021 661 M 746 M 746 M
Net Debt 2021 38 333 M 43 267 M 43 267 M
P/E ratio 2021 62,3x
Yield 2021 4,49%
Capitalization 44 523 M 50 179 M 50 254 M
EV / Sales 2021 1,93x
EV / Sales 2022 1,82x
Nbr of Employees 99 814
Free-Float 100,0%
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 45,54 €
Average target price 62,61 €
Spread / Average Target 37,5%
EPS Revisions
Managers and Directors
Werner Baumann Chairman-Management Board & CEO
Wolfgang U. Nickl Chief Financial Officer
Norbert Winkeljohann Chairman-Supervisory Board
Bijoy Sagar Chief Information Technology Officer
Paul Achleitner Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BAYER AG-5.43%50 628
JOHNSON & JOHNSON1.16%419 109
ROCHE HOLDING AG16.05%336 162
PFIZER, INC.46.70%303 095
NOVO NORDISK A/S67.00%247 254
ELI LILLY AND COMPANY54.21%236 049